Page 38 - Special Access Program News Today

Week in Weed: Canadian serial entrepreneur Bruce Linton is unapologetically blunt, China’s ancient taste for cannabis, and is this the first U.S. senate race…

VANCOUVER, BC / ACCESSWIRE / January 20, 2022 / Clairvoyant Therapeutics, a Canadian biotech company focused on the development of psychedelic drug therapies for the treatment of addiction, is pleased

A doctor and a psychologist say Health Canada’s move to allow physicians to request restricted psychedelic drugs for patients as part of their psychotherapy is a positive step toward transforming mental-health care.

And why advocates say the program doesnt go far enough.

We still have a huge amount of work to do because these medicines could really, really revolutionize the entire mental health-care field, said Dr. Michael…

Move will allow physicians to request restricted psychedelic drugs for patients as part of psychotherapy

Move will allow physicians to request restricted psychedelic drugs for patients as part of psychotherapy

A doctor and a psychologist say Health Canada’s move to allow physicians to request restricted psychedelic drugs for patients as part of their psychotherapy is a positive step toward transforming mental-health care.

A doctor and a psychologist say Health Canada’s move to allow physicians to request restricted psychedelic drugs for patients as part of their psychotherapy is a positive step toward transforming mental-health care.

A doctor and a psychologist say Health Canada’s move to allow physicians to request restricted psychedelic drugs for patients as part of their psychotherapy is a positive step toward transforming mental-health care.